Literature DB >> 34593393

Evaluation of newborn screening for severe combined immunodeficiency (SCID).

Rebecca Nightingale1, Christine Cavanagh2, Andrew R Gennery3.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34593393      PMCID： PMC8463162          DOI： 10.3399/bjgp21X717209

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN： 0960-1643            Impact factor:   6.302


× No keyword cloud information.
  5 in total

1.  Screening of neonatal UK dried blood spots using a duplex TREC screening assay.

Authors:  Stuart P Adams; Samina Rashid; Tharindu Premachandra; Katie Harvey; Adeboye Ifederu; Melanie C Wilson; H Bobby Gaspar
Journal:  J Clin Immunol       Date:  2014-02-28       Impact factor: 8.317

Review 2.  Educational paper. The expanding clinical and immunological spectrum of severe combined immunodeficiency.

Authors:  Mirjam van der Burg; Andy R Gennery
Journal:  Eur J Pediatr       Date:  2011-04-09       Impact factor: 3.183

Review 3.  When Screening for Severe Combined Immunodeficiency (SCID) with T Cell Receptor Excision Circles Is Not SCID: a Case-Based Review.

Authors:  David Buchbinder; Jolan E Walter; Manish J Butte; Wan-Yin Chan; Maria Chitty Lopez; Victoria R Dimitriades; Morna J Dorsey; Diane J Nugent; Jennifer M Puck; Jasjit Singh; Cathleen A Collins
Journal:  J Clin Immunol       Date:  2021-01-07       Impact factor: 8.542

Review 4.  Universal Newborn Screening for Severe Combined Immunodeficiency (SCID).

Authors:  Mirjam van der Burg; Nizar Mahlaoui; Hubert Bobby Gaspar; Sung-Yun Pai
Journal:  Front Pediatr       Date:  2019-09-18       Impact factor: 3.418

5.  Parents' Perspectives and Societal Acceptance of Implementation of Newborn Screening for SCID in the Netherlands.

Authors:  Maartje Blom; Robbert G M Bredius; Marleen E Jansen; Gert Weijman; Evelien A Kemper; Clementien L Vermont; Iris H I M Hollink; Willem A Dik; Joris M van Montfrans; Mariëlle E van Gijn; Stefanie S Henriet; Koen J van Aerde; Wouter Koole; Arjan C Lankester; Eugènie H B M Dekkers; Peter C J I Schielen; Martine C de Vries; Lidewij Henneman; Mirjam van der Burg
Journal:  J Clin Immunol       Date:  2020-10-18       Impact factor: 8.317
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.